These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 26615003)

  • 41. Re-evaluation of the Guideline published by the Acute Liver Failure Study Group of Japan in 1996 to determine the indications of liver transplantation in patients with fulminant hepatitis.
    Mochida S; Nakayama N; Matsui A; Nagoshi S; Fujiwara K
    Hepatol Res; 2008 Oct; 38(10):970-9. PubMed ID: 18462374
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rapid Deterioration of Latent HBV Hepatitis during Cushing Disease and Posttraumatic Stress Disorder after Earthquake.
    Tashiro R; Ogawa Y; Tominaga T
    J Neurol Surg A Cent Eur Neurosurg; 2017 Jul; 78(4):407-411. PubMed ID: 28183144
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Current antiviral practice and course of Hepatitis B virus infection in inflammatory arthritis: a multicentric observational study (A + HBV study).
    Kalyoncu U; Emmungil H; Onat AM; Yılmaz S; Kaşifoglu T; Akar S; İnanç N; Yıldız F; Küçükşahin O; Karadağ Ö; Mercan R; Bes C; Yazısız V; Yılmazer B; Özmen M; Erten Ş; Şenel S; Yazıcı A; Taşçılar K; Kalfa M; Kiraz S; Kısacık B; Pehlivan Y; Kılıç L; Şimşek İ; Çefle A; Akkoç N; Direskeneli H; Erken E; Turgay M; Öztürk MA; Soy M; Aksu K; Dinç A; Ertenli İ
    Eur J Rheumatol; 2015 Dec; 2(4):149-154. PubMed ID: 27708953
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Retrospective study on the impact of hepatitis B and hepatitis C virus infection on hematopoietic stem cell transplantation in Japan.
    Hamaguchi M; Yamada H; Gondo H; Takemoto Y; Morishima Y; Kodera Y
    Int J Hematol; 2002 Apr; 75(3):324-31. PubMed ID: 11999365
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Management of psoriasis patients with hepatitis B or hepatitis C virus infection.
    Bonifati C; Lora V; Graceffa D; Nosotti L
    World J Gastroenterol; 2016 Jul; 22(28):6444-55. PubMed ID: 27605880
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Nucleos(t)ides as prophylaxis for the reactivation of hepatitis B virus in immunosuppressed patients].
    Fan LY; Zhou Z; Zhong S; Ling N; Wang ZY; Shi XF; Zhang DZ; Ren H
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):429-33. PubMed ID: 19567021
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma.
    Chu CM
    J Gastroenterol Hepatol; 2000 May; 15 Suppl():E25-30. PubMed ID: 10921378
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Hepatitis B tests as screenings for the reactivation of HBV infection at Fukuoka University Hospital].
    Matsuzaki T; Ohkubo K; Kawashima H; Matsunaga A
    Rinsho Byori; 2011 Jun; 59(6):559-64. PubMed ID: 21815477
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Deteriorated outcome of recent patients with acute liver failure and late-onset hepatic failure caused by infection with hepatitis A virus: A subanalysis of patients seen between 1998 and 2015 and enrolled in nationwide surveys in Japan.
    Nakao M; Nakayama N; Uchida Y; Tomiya T; Oketani M; Ido A; Tsubouchi H; Takikawa H; Mochida S
    Hepatol Res; 2019 Aug; 49(8):844-852. PubMed ID: 30957325
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Discussion and evaluation of diagnostic criteria for hepatitis B virus-related acute-on-chronic pre-liver failure].
    Li C; Zhu B; Lyu S; You SL
    Zhonghua Gan Zang Bing Za Zhi; 2018 Feb; 26(2):130-135. PubMed ID: 29804380
    [No Abstract]   [Full Text] [Related]  

  • 51. Management of acute hepatitis B and reactivation of hepatitis B.
    Jindal A; Kumar M; Sarin SK
    Liver Int; 2013 Feb; 33 Suppl 1():164-75. PubMed ID: 23286861
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Fulminant hepatic failure and hepatitis B virus reactivation: case reports and analyses of the pathological mechanism].
    Tian Y; Gong G
    Zhonghua Gan Zang Bing Za Zhi; 2014 Apr; 22(4):272-6. PubMed ID: 25173225
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Incidence of hepatitis virus infection and severe liver dysfunction in patients receiving chemotherapy for hematologic malignancies.
    Kawatani T; Suou T; Tajima F; Ishiga K; Omura H; Endo A; Ohmura H; Ikuta Y; Idobe Y; Kawasaki H
    Eur J Haematol; 2001 Jul; 67(1):45-50. PubMed ID: 11553266
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hepatitis B virus carriers in the treatment of malignant lymphoma: an epidemiological study in Japan.
    Kumagai K; Takagi T; Nakamura S; Sawada U; Kura Y; Kodama F; Shimano S; Kudoh I; Nakamura H; Sawada K; Ohnoshi T
    Ann Oncol; 1997; 8 Suppl 1():107-9. PubMed ID: 9187442
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Early Hepatitis B Surface Antigen Seroclearance Following Antiviral Treatment in Patients with Reactivation of Resolved Hepatitis B.
    Lee HL; Jang JW; Han JW; Lee SW; Bae SH; Choi JY; Han NI; Yoon SK; Kim HJ; Lee S; Cho SG; Min CK; Kim DW; Lee JW
    Dig Dis Sci; 2019 Oct; 64(10):2992-3000. PubMed ID: 30982209
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reactivation of hepatitis B virus during targeted therapies for cancer and immune-mediated disorders.
    Viganò M; Serra G; Casella G; Grossi G; Lampertico P
    Expert Opin Biol Ther; 2016 Jul; 16(7):917-26. PubMed ID: 27088278
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prophylaxis of hepatitis B reactivation with immunosuppressive therapy in rheumatic diseases. Orientations for clinical practice.
    Nunes J; Marinho RT; Fonseca JE; Pereira da Silva JA; Velosa J
    Acta Reumatol Port; 2011; 36(2):110-8. PubMed ID: 21841730
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interferon and cyclosporin A in the treatment of fulminant viral hepatitis.
    Yoshiba M; Sekiyama K; Inoue K; Fujita R
    J Gastroenterol; 1995 Feb; 30(1):67-73. PubMed ID: 7719417
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Entecavir versus lamivudine for hepatitis B prophylaxis in patients with haematological disease.
    Chen FW; Coyle L; Jones BE; Pattullo V
    Liver Int; 2013 Sep; 33(8):1203-10. PubMed ID: 23522150
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hepatitis B Reactivation Associated With Immune Suppressive and Biological Modifier Therapies: Current Concepts, Management Strategies, and Future Directions.
    Loomba R; Liang TJ
    Gastroenterology; 2017 May; 152(6):1297-1309. PubMed ID: 28219691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.